Pharmacogenetic variability of tuberculosis biomarkers in native and mestizo Peruvian populations
Abstract In Peru, 29 292 people were diagnosed with tuberculosis in 2022. Although tuberculosis treatments are effective, 3.4%-13% are associated with significant adverse drug reactions, with drug‐induced liver injury (DILI) considered the most predominant. Among the first‐line antituberculosis drug...
Saved in:
Main Authors: | Luis Jaramillo‐Valverde (Author), Kelly S. Levano (Author), David D. Tarazona (Author), Silvia Capristano (Author), Cesar Sanchez (Author), Julio A. Poterico (Author), Eduardo Tarazona‐Santos (Author), Heinner Guio (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2024-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Variation in Actionable Pharmacogenetic Markers in Natives and Mestizos From Mexico
by: Vanessa Gonzalez-Covarrubias, et al.
Published: (2019) -
Frequency of CYP2D6*3 and *4 and metabolizer phenotypes in three mestizo Peruvian populations
by: Angel T. Alvarado, et al.
Published: (2021) -
Population genetics of PDE4B (phosphodiesterase‐4B) in neglected Native Americans: Implications for cancer pharmacogenetics
by: Rennan Garcias Moreira, et al.
Published: (2022) -
Frequency of CYP1A1*2A polymorphisms and deletion of the GSMT1 gene in a Peruvian mestizo population
by: Angel Tito Alvarado, et al.
Published: (2021) -
Rhinoplasty in Mestizo and Black Noses
by: Bernaldo Canto Vidal, et al.
Published: (2010)